Medivation shares pop after report that at least five companies interested in deal | Len Mistretta

  Shares of Medivation briefly popped more than 4 percent Wednesday after a report that at least five pharmaceutical companies expressed interest in buying the bio pharmaceutical company.

The stock later pared its gains and ended the day up about 2 percent.
Merck is one of five pharmaceutical companies who have expressed interest in buying Medivation, according to Reuters, citing sources who asked not be identified because the sale process details are confidential.
The other companies listed are: Sanofi, Pfizer, Celgene and Gilead Sciences.

For the past several months, reports have surfaced of drug makers approaching Medivation to express interest in an acquisition.   Read More....